In addition, TGF-β inhibition was demonstrated to decrease the formation of new blood vessels in xenograft prostate cancer model [33], as well as apoptosis rates of prostatic myofibroblasts [34]. The gene discussed is TGFB1; the disease is prostate carcinoma.